SHARE
Small Molecule Drug Discovery Market

Small Molecule Drug Discovery Market Forecasts to 2028 – Global Analysis By Type (Tablets, Pills), Therapeutic Area (Oncology, Orthopedics, Lead Identification, Hit Generation and Selection), Process Phase and By Geography

4.7 (91 reviews)
Published: November 2021 ID: SMRC21184
4.7 (91 reviews)
Published: November 2021 ID: SMRC21184

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Small Molecule Drug Discovery Market is accounted for $32,150.00 million in 2020 and is expected to reach $71,462.66 million by 2028 growing at a CAGR of 10.5% during the forecast period. Rise in drug discovery, development and rising usage of the drugs in the treatment of chronic diseases are driving the market growth. However, high cost of drugs is hindering the market growth.

Small molecule drug is a substance that can quickly enter the cells due to its low molecular weight. After entering the cells, it may affect the other molecules like proteins and may cause the cancer cells to die. There are two phases of developing new small molecule drugs. Small molecule drugs are different from other drugs which have a large molecular weight. So, these targeted therapies are small-molecule drugs or small molecule inhibitors.

Based on the process phase, the lead optimization and refinement segment is going to have lucrative growth during the forecast period due to increasing strength, selectivity, or pharmacokinetic parameters, rising in cancer and other diseases encouraging investments in lead optimization.

By geography, North America is going to have high growth during the forecast period due to the rising increasing number of contract organizations for research and development. Moreover, the United States is focusing on R&D activities to meet the rising demands of its people, finally leading the market of North America.

Some of the key players profiled in the Small Molecule Drug Discovery Market include Astrazeneca, Boehringer Ingelheim Gmbh, Bristol- Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Pfizer Inc and Teva Pharmaceuticals.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 32,150.00 million

Estimated Period:

2020

Compound Annual Growth Rate (CAGR)  from 2020 to 2028:

10.5%

Predicted 2028 Value:

USD 71,462.66 million

Forecast Years:

2021-2028

Tables, Graphs & Figures

129

Chapters Covered:

Type, Therapeutic Area, Process Phase and Region

Core Drivers and Opportunities:

  • Rise in drug discovery
  • Rising usage of the drugs in the treatment of chronic diseases

Restraining Factors & Market Threats:

  • High cost of drugs
  • Strict regulations for drug development


Types Covered:
• Tablets
• Pills   

Therapeutic Areas Covered:
• Dermatology
• Respiratory
• Cardiovascular
• Immunology
• Anti-Infective
• Oncology
• Central Nervous System
• Orthopedics
• Rare Diseases & Metabolic Disorders 
• Gastrointestinal

Process Phases Covered:
• Target Identification (ID)/Validation
• Preclinical Development
• Lead Optimization and Refinement
• Lead Identification
• Hit Generation and Selection

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Small Molecule Drug Discovery Market is majorly driven by rise in drug discovery, development and rising usage of the drugs in the treatment of chronic diseases.

The lead optimization and refinement segment is growing at a highest CAGR due to increasing strength, selectivity, or pharmacokinetic parameters, rising in cancer and other diseases encouraging investments in lead optimization.

North America dominated with a significant market share to the rising increasing number of contract organizations for research and development. Moreover, the United States is focusing on R&D activities to meet the rising demands of its people, finally leading the market of North America.

Asia Pacific market is growing at a highest CAGR due to the increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments in the region.

Key players in Small Molecule Drug Discovery Market include Astrazeneca, Boehringer Ingelheim Gmbh, Bristol- Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Pfizer Inc and Teva Pharmaceuticals.

Select License Type

NEW YEAR SALE
Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials